Liver mass surgery: Difference between revisions
Jump to navigation
Jump to search
Aditya Ganti (talk | contribs) No edit summary |
m (Bot: Removing from Primary care) |
||
| (One intermediate revision by one other user not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Liver mass}} | {{Liver mass}} | ||
{{CMG}} ; {{AE}} {{ADG}} | {{CMG}}; {{AE}} {{ADG}} | ||
==Overview== | ==Overview== | ||
In the majority of cases of benign hepatic tumors, patients are asymptomatic, and no treatment is indicated. The main indication for treatment is the presence of significant clinical [[symptoms]] or suspicion of [[malignancy]] or fear of malignant transformation. Surgery is the mainstay of treatment for symptomatic benign liver lesions. | In the majority of cases of benign hepatic tumors, patients are asymptomatic, and no treatment is indicated. The main indication for treatment is the presence of significant clinical [[symptoms]] or suspicion of [[malignancy]] or fear of malignant transformation. Surgery is the mainstay of treatment for symptomatic benign liver lesions. | ||
| Line 14: | Line 14: | ||
**Certainty of the diagnosis | **Certainty of the diagnosis | ||
'''The following table summarizes surgical management of most common benign liver lesions that cause liver mass:'''<ref name="pmid16541615">{{cite journal |vauthors=Skalicky T, Treska V, Sutnar A, Liska V, Mirka H, Ohlidalova K, Ferda J |title=Surgical treatment of benign liver tumors |journal=Bratisl Lek Listy |volume=106 |issue=10 |pages=330–2 |year=2005 |pmid=16541615 |doi= |url=}}</ref><ref name="pmid28289336">{{cite journal |vauthors=Reddy KR |title=Benign Lesions of the Liver |journal=Gastroenterol Hepatol (N Y) |volume=2 |issue=5 |pages=325–326 |year=2006 |pmid=28289336 |pmc=5338186 |doi= |url=}}</ref><ref name="pmid23297727">{{cite journal |vauthors=Mezhir JJ, Fourman LT, Do RK, Denton B, Allen PJ, D'Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR |title=Changes in the management of benign liver tumours: an analysis of 285 patients |journal=HPB (Oxford) |volume=15 |issue=2 |pages=156–63 |year=2013 |pmid=23297727 |pmc=3719923 |doi=10.1111/j.1477-2574.2012.00556.x |url=}}</ref><ref name="pmid17188079">{{cite journal |vauthors=Ibrahim S, Chen CL, Wang SH, Lin CC, Yang CH, Yong CC, Jawan B, Cheng YF |title=Liver resection for benign liver tumors: indications and outcome |journal=Am. J. Surg. |volume=193 |issue=1 |pages=5–9 |year=2007 |pmid=17188079 |doi=10.1016/j.amjsurg.2006.04.017 |url=}}</ref><ref name="pmid9361515">{{cite journal |vauthors=Weimann A, Ringe B, Klempnauer J, Lamesch P, Gratz KF, Prokop M, Maschek H, Tusch G, Pichlmayr R |title=Benign liver tumors: differential diagnosis and indications for surgery |journal=World J Surg |volume=21 |issue=9 |pages=983–90; discussion 990–1 |year=1997 |pmid=9361515 |doi= |url=}}</ref> | '''The following table summarizes surgical management of most common benign liver lesions that cause liver mass:'''<ref name="pmid16541615">{{cite journal |vauthors=Skalicky T, Treska V, Sutnar A, Liska V, Mirka H, Ohlidalova K, Ferda J |title=Surgical treatment of benign liver tumors |journal=Bratisl Lek Listy |volume=106 |issue=10 |pages=330–2 |year=2005 |pmid=16541615 |doi= |url=}}</ref><ref name="pmid28289336">{{cite journal |vauthors=Reddy KR |title=Benign Lesions of the Liver |journal=Gastroenterol Hepatol (N Y) |volume=2 |issue=5 |pages=325–326 |year=2006 |pmid=28289336 |pmc=5338186 |doi= |url=}}</ref><ref name="pmid23297727">{{cite journal |vauthors=Mezhir JJ, Fourman LT, Do RK, Denton B, Allen PJ, D'Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR |title=Changes in the management of benign liver tumours: an analysis of 285 patients |journal=HPB (Oxford) |volume=15 |issue=2 |pages=156–63 |year=2013 |pmid=23297727 |pmc=3719923 |doi=10.1111/j.1477-2574.2012.00556.x |url=}}</ref><ref name="pmid17188079">{{cite journal |vauthors=Ibrahim S, Chen CL, Wang SH, Lin CC, Yang CH, Yong CC, Jawan B, Cheng YF |title=Liver resection for benign liver tumors: indications and outcome |journal=Am. J. Surg. |volume=193 |issue=1 |pages=5–9 |year=2007 |pmid=17188079 |doi=10.1016/j.amjsurg.2006.04.017 |url=}}</ref><ref name="pmid9361515">{{cite journal |vauthors=Weimann A, Ringe B, Klempnauer J, Lamesch P, Gratz KF, Prokop M, Maschek H, Tusch G, Pichlmayr R |title=Benign liver tumors: differential diagnosis and indications for surgery |journal=World J Surg |volume=21 |issue=9 |pages=983–90; discussion 990–1 |year=1997 |pmid=9361515 |doi= |url=}}</ref> | ||
{| | {| | ||
! rowspan="3" | | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Disease | ||
! rowspan="3" |Asymptomatic | ! rowspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Asymptomatic | ||
! colspan="3" |Symptomatic | ! colspan="3" align="center" style="background:#4479BA; color: #FFFFFF;" + |Symptomatic | ||
|- | |- | ||
! colspan="2" |Surgical | ! colspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Surgical Interventions | ||
! rowspan="2" |Non-Surgical | ! rowspan="2" align="center" style="background:#4479BA; color: #FFFFFF;" + |Non-Surgical Interventions | ||
|- | |- | ||
!Indications | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Indications | ||
!Options | ! align="center" style="background:#4479BA; color: #FFFFFF;" + |Options | ||
|- | |- | ||
|Hepatic adenoma | ! align="center" style="background:#DCDCDC;" + |Hepatic adenoma | ||
|The European Association for Study of the Liver recommends | | align="left" style="background:#F5F5F5;" + |The European Association for Study of the Liver recommends: | ||
*Discontinuation of contraceptive medication | *Discontinuation of contraceptive medication | ||
*Close observation of the lesion with repeated imaging and alpha fetoprotein | *Close observation of the lesion with repeated imaging and alpha-fetoprotein | ||
**Contrast-enhanced MRI at a six 6 month interval to determine if there is regression | **Contrast-enhanced MRI at a six 6 month interval to determine if there is a regression | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Symptomatic patients | * Symptomatic patients | ||
* Large lesions (>5 cm) | * Large lesions (>5 cm) | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
*Enucleation | *Enucleation | ||
*Resection | *Resection | ||
*Liver transplantation | *Liver transplantation | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
*Transarterial embolization | *Transarterial embolization | ||
*Radiofrequency ablation | *Radiofrequency ablation | ||
|- | |- | ||
|Hepatic Hemangioma | ! align="center" style="background:#DCDCDC;" + |Hepatic Hemangioma | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Patients with lesions <1.5 cm | * Patients with lesions <1.5 cm | ||
** Reassurance | ** Reassurance | ||
** Observation | ** Observation | ||
* Patients with a rapid growth of a hemangioma or with lesions >5 cm | * Patients with a rapid growth of a hemangioma or with lesions >5 cm | ||
** Repeat imaging in 6 to 12 months | ** Repeat imaging in 6 to 12 months | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Abdominal pain | * Abdominal pain | ||
* Symptoms suggestive of extrinsic compression of adjacent structures | * Symptoms suggestive of extrinsic compression of adjacent structures | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Liver resection | * Liver resection | ||
* Enucleation | * Enucleation | ||
* Hepatic artery ligation | * Hepatic artery ligation | ||
* Liver transplantation | * Liver transplantation | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Hepatic artery embolization | * Hepatic artery embolization | ||
* Radiotherapy | * Radiotherapy | ||
* Interferon alfa-2a | * Interferon alfa-2a | ||
|- | |- | ||
|Focal nodular hyperplasia | ! align="center" style="background:#DCDCDC;" + |Focal nodular hyperplasia | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* No indication for therapy unless they are symptomatic | * No indication for therapy unless they are symptomatic | ||
* Follow-up imaging studies | * Follow-up imaging studies | ||
** | ** Confirm the stability of the lesion after 3-6 months | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* N/A | * N/A | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* N/A | * N/A | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* N/A | * N/A | ||
|- | |- | ||
|Simple Hepatic cyst | ! align="center" style="background:#DCDCDC;" + |Simple Hepatic cyst | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* No treatment | * No treatment | ||
* Cysts >4 cms in diameter | * Cysts >4 cms in diameter | ||
** Periodic USG 3 months after initial diagnosis | ** Periodic USG 3 months after initial diagnosis | ||
** 6-12 months follow up | ** 6-12 months follow up | ||
** If cyst remained stable no further treatment/followup | ** If cyst remained stable, no further treatment/followup | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Abdominal pain | * Abdominal pain | ||
* Growing cyst | * Growing cyst | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Needle aspiration with or without injection of sclerosing agents | * Needle aspiration with or without injection of sclerosing agents | ||
* Internal drainage with cystojejunostomy | * Internal drainage with cystojejunostomy | ||
* Wide unroofing/cyst resection | * Wide unroofing/cyst resection | ||
* Liver resection | * Liver resection | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* N/A | |||
|- | |- | ||
|Non-Invasive Cystadenoma | ! align="center" style="background:#DCDCDC;" + |Non-Invasive Cystadenoma | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Surgery | * Surgery | ||
** High potential of malignant transformation | ** High potential of malignant transformation | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* N/A | * N/A | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Removal of the cyst | * Removal of the cyst | ||
** Partial excision | ** Partial excision | ||
| Line 104: | Line 104: | ||
* Hepatic resection | * Hepatic resection | ||
** Considered whenever a cystic lesion is suspected of containing invasive carcinoma | ** Considered whenever a cystic lesion is suspected of containing invasive carcinoma | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* N/A | * N/A | ||
|- | |- | ||
|Invasive cystadenoma | ! align="center" style="background:#DCDCDC;" + |Invasive cystadenoma | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* N/A | * N/A | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* N/A | * N/A | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Liver resection | * Liver resection | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Radiation | * Radiation | ||
* Chemotherapy | * Chemotherapy | ||
|- | |- | ||
|Hepatic abscess | ! align="center" style="background:#DCDCDC;" + |Hepatic abscess | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* N/A | * N/A | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Percutaneous | * Percutaneous | ||
** Abscess size is more than 5 cm | ** Abscess size is more than 5 cm | ||
* Surgical drainage | * Surgical drainage | ||
** Ruptured [[abscess]] | ** Ruptured [[abscess]] | ||
** [[Hyperbilirubinemia]] or renal | ** [[Hyperbilirubinemia]] or renal impairment | ||
** Multiple and loculated abscesses which cannot be easily accessible by percutaneous drainage | ** Multiple and loculated abscesses which cannot be easily accessible by percutaneous drainage | ||
** Inadequate drainage through percutaneous methods | ** Inadequate drainage through percutaneous methods | ||
| Line 132: | Line 132: | ||
** Bile duct stones | ** Bile duct stones | ||
** Strictures | ** Strictures | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
* Percutaneous Drainage | * Percutaneous Drainage | ||
* Surgical Drainage | * Surgical Drainage | ||
* ERCP | * ERCP | ||
| | | align="left" style="background:#F5F5F5;" + | | ||
*N/A | |||
|} | |} | ||
==References== | |||
{{Reflist|2}} | |||
[[Category:Medicine]] | [[Category:Medicine]] | ||
[[Category:Gastroenterology]] | |||
[[Category:Hepatology]] | [[Category:Hepatology]] | ||
[[Category: | [[Category:Oncology]] | ||
[[Category:Up-To-Date]] | |||
[[Category:Surgery]] | [[Category:Surgery]] | ||
Latest revision as of 22:32, 29 July 2020
|
Liver Mass Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Liver mass surgery On the Web |
|
American Roentgen Ray Society Images of Liver mass surgery |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aditya Ganti M.B.B.S. [2]
Overview
In the majority of cases of benign hepatic tumors, patients are asymptomatic, and no treatment is indicated. The main indication for treatment is the presence of significant clinical symptoms or suspicion of malignancy or fear of malignant transformation. Surgery is the mainstay of treatment for symptomatic benign liver lesions.
Surgery
In the majority of cases of benign hepatic tumors, patients are asymptomatic, and no treatment is indicated. The main indication for treatment is the presence of significant clinical symptoms or suspicion of malignancy or fear of malignant transformation. Surgery is the mainstay of treatment for symptomatic benign liver lesions.
- Management of lesions also depends upon:
- Symptoms
- Size
- Number
- Location
- Certainty of the diagnosis
The following table summarizes surgical management of most common benign liver lesions that cause liver mass:[1][2][3][4][5]
| Disease | Asymptomatic | Symptomatic | ||
|---|---|---|---|---|
| Surgical Interventions | Non-Surgical Interventions | |||
| Indications | Options | |||
| Hepatic adenoma | The European Association for Study of the Liver recommends:
|
|
|
|
| Hepatic Hemangioma |
|
|
|
|
| Focal nodular hyperplasia |
|
|
|
|
| Simple Hepatic cyst |
|
|
|
|
| Non-Invasive Cystadenoma |
|
|
|
|
| Invasive cystadenoma |
|
|
|
|
| Hepatic abscess |
|
|
|
|
References
- ↑ Skalicky T, Treska V, Sutnar A, Liska V, Mirka H, Ohlidalova K, Ferda J (2005). "Surgical treatment of benign liver tumors". Bratisl Lek Listy. 106 (10): 330–2. PMID 16541615.
- ↑ Reddy KR (2006). "Benign Lesions of the Liver". Gastroenterol Hepatol (N Y). 2 (5): 325–326. PMC 5338186. PMID 28289336.
- ↑ Mezhir JJ, Fourman LT, Do RK, Denton B, Allen PJ, D'Angelica MI, DeMatteo RP, Fong Y, Jarnagin WR (2013). "Changes in the management of benign liver tumours: an analysis of 285 patients". HPB (Oxford). 15 (2): 156–63. doi:10.1111/j.1477-2574.2012.00556.x. PMC 3719923. PMID 23297727.
- ↑ Ibrahim S, Chen CL, Wang SH, Lin CC, Yang CH, Yong CC, Jawan B, Cheng YF (2007). "Liver resection for benign liver tumors: indications and outcome". Am. J. Surg. 193 (1): 5–9. doi:10.1016/j.amjsurg.2006.04.017. PMID 17188079.
- ↑ Weimann A, Ringe B, Klempnauer J, Lamesch P, Gratz KF, Prokop M, Maschek H, Tusch G, Pichlmayr R (1997). "Benign liver tumors: differential diagnosis and indications for surgery". World J Surg. 21 (9): 983–90, discussion 990–1. PMID 9361515.